David Hyman

David Hyman

Financieel Directeur/CFO bij MEDICENNA THERAPEUTICS CORP.

Vermogen: 31 200 $ op 31-05-2026

Finance
Commercial Services
Consumer Services

Profiel

David Hyman is Chief Financial Officer & Secretary at Medicenna Therapeutics Corp.
since 2024.
Former roles include Chief Financial Officer & Secretary at Rakovina Therapeutics, Inc. from 2021 to 2025, Chief Financial Officer & Partner at Tandem Accounting Group Ltd. from 2019 to 2024, Chief Financial Officer at KORT Payments, Inc. from 2016 to 2018, Vice President at Camcor Partners, Inc. from 2008 to 2015, Vice President at Camcor Capital, Inc., Director at Serafina Energy Ltd., Chief Financial Officer, Secretary & Director at HAW Capital Corp., Research Analyst at Raymond James Ltd. (Broker), Senior Manager at Deloitte LLP, Chief Financial Officer at TheraCann International Benchmark Corp., and Chief Financial Officer at Tandem Innovation Group.
Education includes an undergraduate degree from the University of Calgary, conferred in 1995.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
28-05-2026 100.000 ( 0,15% ) 31 200 $ 31-05-2026

Actieve functies van David Hyman

BedrijvenFunctieBegin
MEDICENNA THERAPEUTICS CORP. Financieel Directeur/CFO 14-02-2024

Eerdere bekende functies van David Hyman

BedrijvenFunctieEinde
RAKOVINA THERAPEUTICS INC. Financieel Directeur/CFO 01-05-2025
Financieel Directeur/CFO 01-01-2024
Financieel Directeur/CFO 01-07-2018
Corporate Officer/Principal 01-08-2015
Tandem Innovation Group
Financieel Directeur/CFO -
Ervaring van David Hyman in detail bekijken

Opleiding van David Hyman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

91

Eerstegraads connecties

13

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit13

Finance

Finance

Consumer Services

Finance

Commercial Services

Energy Minerals

Commercial Services

Finance

Health Technology

Commercial Services

Commercial Services

Finance

Tandem Innovation Group

  1. Beurs
  2. Insiders
  3. David Hyman